|
Market Closed -
Nasdaq
16:00:00 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 2.490 USD | -2.54% |
|
-17.00% | -28.86% |
| Market Cap | 108M 98.16M 90.75M 81.9M 154M 10.06B 160M 1.1B 433M 5.43B 404M 395M 17.14B | P/E 2026 * |
-12.7x | P/E 2027 * | -13.4x |
|---|---|---|---|---|---|
| Enterprise Value | 108M 98.16M 90.75M 81.9M 154M 10.06B 160M 1.1B 433M 5.43B 404M 395M 17.14B | EV / Sales 2026 * |
1.81x | EV / Sales 2027 * | 1.64x |
| Free-Float |
84.43% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APYX | Delayed | |
| APYX | Real-time | ||
| BOV | Delayed | ||
| BOV | Delayed | ||
| BOV | Real-time | ||
| BOV | Real-time |
Last Transcript: Apyx Medical Corporation
| 1 day | -2.54% | ||
| 1 week | -17.00% | ||
| Current month | -4.23% | ||
| 1 month | +2.89% | ||
| 3 months | -19.94% | ||
| 6 months | -35.66% | ||
| Current year | -28.86% |
| 1 week | 2.38 | 2.93 | |
| 1 month | 2.25 | 3.3 | |
| Current year | 2.25 | 5.08 | |
| 1 year | 2.25 | 5.08 | |
| 3 years | 0.76 | 5.08 | |
| 5 years | 0.76 | 17.5 | |
| 10 years | 0.76 | 17.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 60 | 2017-12-14 |
Matthew Hill
DFI | Director of Finance/CFO | 57 | 2023-12-03 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 79 | 2011-03-14 |
Charles Goodwin
BRD | Director/Board Member | 60 | 2017-12-14 |
| Director/Board Member | 78 | 2019-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/26 | Exercice | Director | 29,024 | 0.0693% | ||
| 6/11/26 | Free | Chief Operating Officer | 88,044 | 0.2103% | ||
| 3/15/26 | Exercice | Executive/Senior Manager | 74,000 | 0.1804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.54% | -17.00% | -34.65% | +8.26% | 108M | ||
| -0.22% | -4.40% | -19.63% | +3.24% | 181B | ||
| -1.56% | -0.88% | -0.08% | +34.01% | 125B | ||
| +0.19% | -0.20% | -11.51% | +9.98% | 121B | ||
| +1.12% | -3.62% | -42.71% | +0.79% | 90.52B | ||
| -0.64% | -0.45% | -3.69% | +77.76% | 66.9B | ||
| +0.31% | +0.73% | +12.35% | -7.53% | 58.68B | ||
| +1.19% | -0.59% | +4.22% | +47.69% | 54.38B | ||
| +0.86% | -0.15% | -1.84% | +38.65% | 48.46B | ||
| +0.84% | +0.71% | +1.50% | -0.26% | 35.4B | ||
| Average | -0.09% | -1.51% | -9.60% | +21.26% | 78B | |
| Weighted average by Cap. | -0.07% | -1.52% | -10.44% | +19.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 59.59M 54.35M 50.25M 45.35M 85.41M 5.57B 88.77M 607M 240M 3.01B 224M 219M 9.49B | 65.8M 60.01M 55.49M 50.07M 94.31M 6.15B 98.02M 670M 265M 3.32B 247M 242M 10.48B |
| Net income | -8.73M -7.96M -7.36M -6.64M -12.51M -816M -13M -88.88M -35.13M -440M -32.74M -32.06M -1.39B | -8.58M -7.82M -7.23M -6.53M -12.29M -802M -12.78M -87.36M -34.53M -433M -32.18M -31.51M -1.37B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | US$2.490 | -2.54% | 188,655 |
| 26-11-17 | US$2.555 | -3.58% | 46,115 |
| 26-11-16 | US$2.650 | -5.69% | 71,230 |
| 26-11-13 | US$2.810 | -2.77% | 43,009 |
| 26-11-12 | US$2.890 | -3.67% | 128,115 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- APYX Stock
Select your edition
All financial news and data tailored to specific country editions
















